FLOSEAL FOR PREVENTING SYMPTOMATIC LYMPHOCELE AFTER PELVIC AND/OR PARA-AORTIC LYMPHADENECTOMY IN GYNECOLOGICAL CANCERS: A RANDOMIZED CONTROLLED TRIAL

被引:0
|
作者
Baek, Min-Hyun [1 ]
Park, Jeong-Yeol [2 ]
Nam, Joo-Hyun [3 ]
机构
[1] Asan Med Ctr, Anyang, South Korea
[2] Univ Ulsan, Coll Med, Seoul, South Korea
[3] Hallym Univ, Sacred Heart Hosp, Seoul, South Korea
关键词
D O I
10.1136/ijgc-2023-ESGO.753
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
407
引用
收藏
页码:A355 / A356
页数:2
相关论文
共 50 条
  • [21] Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity
    Yann Delpech
    Christine Haie-Meder
    Annie Rey
    Yaelle Zafrani
    Catherine Uzan
    Sebastien Gouy
    Patricia Pautier
    Catherine Lhommé
    Pierre Duvillard
    Damienne Castaigne
    Philippe Morice
    Annals of Surgical Oncology, 2007, 14 : 3223 - 3231
  • [22] Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study
    Kim, Yun Hwan
    Shin, Hyun Joo
    Ju, Woong
    Kim, Seung-Cheol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2017, 28 (03)
  • [23] Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial
    Yoshikawa, T.
    Sasako, M.
    Sano, T.
    Nashimoto, A.
    Kurita, A.
    Tsujinaka, T.
    Tanigawa, N.
    Yamamoto, S.
    BRITISH JOURNAL OF SURGERY, 2006, 93 (12) : 1526 - 1529
  • [24] Laparoscopic para-aortic and pelvic lymphadenectomy and radical hysterectomy in a patient with cervical cancer, six months after primary chemoradiation
    Zygouris, D.
    Kotsopoulos, I. C.
    Chalvatzas, N.
    Maltaris, T.
    Kartsiounis, V.
    Kavallaris, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (05) : 484 - 486
  • [25] Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes
    Kubo-Kaneda, Michiko
    Kondo, Eiji
    Enomoto, Naosuke
    Okamoto, Kota
    Toriyabe, Kuniaki
    Nii, Masafumi
    Yoshida, Kenta
    Ikeda, Tomoaki
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (04):
  • [26] Proposal of a concept and design of a randomized phase III trial investigating the survival effect of para-aortic lymphadenectomy in endometrial cancer
    Watari, Hidemichi
    Todo, Yukiharu
    Kang, Sokbom
    Odagiri, Tetsuji
    Sakuragi, Noriaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (02) : 312 - 316
  • [27] Prospective Non-randomized Control Trial on Role of Systematic High Para-Aortic Lymphadenectomy in Endometrial Cancer: Indian Study
    S. P. Somashekhar
    C. Rohit Kumar
    Anil Jampani
    Vijay Ahuja
    Sushmita H. Rakshit
    K. R. Ashwin
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [28] Prospective Non-randomized Control Trial on Role of Systematic High Para-Aortic Lymphadenectomy in Endometrial Cancer: Indian Study
    Somashekhar, S. P.
    Kumar, C. Rohit
    Jampani, Anil
    Ahuja, Vijay
    Rakshit, Sushmita H.
    Ashwin, K. R.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (01)
  • [29] Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3)
    Watari, Hidemichi
    Katayama, Hiroshi
    Shibata, Taro
    Ushijima, Kimio
    Satoh, Toyomi
    Onda, Takashi
    Aoki, Daisuke
    Fukuda, Haruhiko
    Yaegashi, Nobuo
    Sakuragi, Noriaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (10) : 986 - 990
  • [30] IMPACT OF SYSTEMATIC PELVIC AND PARA-AORTIC LYMPHADENECTOMY AFTER SIX CYCLES OF NEOADJUVANT CHEMOTHERAPY IN HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Lopes, A.
    Genta, M. L. Nogueira D.
    Mendonza Lopez, R. V.
    del Pilar Estevez Diz, M.
    Paula Carvalho, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A27 - A27